GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.6124
-0.0155 (-2.47%)
Oct 31, 2025, 12:06 PM EDT - Market open
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $2.18 million as of October 31, 2025. Its market cap has decreased by -52.64% in one year.
Market Cap
2.18M
Enterprise Value
-2.99M
1-Year Change
-52.64%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $2.18M, a decrease of -97.38%. That is a compound annual growth rate of -38.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 2.10M | -69.12% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.23B |
| Johnson & Johnson | 449.42B |
| AbbVie | 401.96B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.36B |